Abeona Therapeutics Inc
NASDAQ:ABEO

Watchlist Manager
Abeona Therapeutics Inc Logo
Abeona Therapeutics Inc
NASDAQ:ABEO
Watchlist
Price: 5.87 USD 5.39% Market Closed
Market Cap: 300.3m USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
-11%
Revenue
Forecast
+6%
Operating Income
Forecast
+35%
Net Income
Forecast
+67%

Wall Street
Price Targets

ABEO Price Targets Summary
Abeona Therapeutics Inc

Wall Street analysts forecast ABEO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ABEO is 20.33 USD with a low forecast of 11.11 USD and a high forecast of 28.88 USD.

ABEO Lowest Forecast
Wall Street Target
11.11 USD
89% Upside
ABEO Average Forecast
Wall Street Target
20.33 USD
246% Upside
ABEO Highest Forecast
Wall Street Target
28.88 USD
392% Upside
Lowest
Price Target
11.11 USD
89% Upside
Average
Price Target
20.33 USD
246% Upside
Highest
Price Target
28.88 USD
392% Upside
Abeona Therapeutics Inc Competitors:
Price Targets
CRSP
CRISPR Therapeutics AG
58% Upside
PTGX
Protagonist Therapeutics Inc
39% Upside
GNS
Genus PLC
24% Upside
AGIO
Agios Pharmaceuticals Inc
56% Upside
CRSP
CRISPR Therapeutics AG
58% Upside
PTGX
Protagonist Therapeutics Inc
39% Upside
GNS
Genus PLC
24% Upside
AGIO
Agios Pharmaceuticals Inc
56% Upside
J
7774
Japan Tissue Engineering Co Ltd
118% Upside
ALKS
Alkermes Plc
43% Upside
LGND
Ligand Pharmaceuticals Inc
29% Upside
HALO
Halozyme Therapeutics Inc
34% Upside

Revenue
Forecast

Revenue Estimate
Abeona Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-15%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Abeona Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Abeona Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-96%
Average Miss
What are analyst estimates?

See Also

Summary
ABEO intrinsic value, competitors valuation, and company profile.
DCF Valuation
ABEO stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ABEO stock valuation using valuation multiples.
Wall Street Estimates
ABEO price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ABEO stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ABEO's stock price target?
Price Target
20.33 USD

According to Wall Street analysts, the average 1-year price target for ABEO is 20.33 USD with a low forecast of 11.11 USD and a high forecast of 28.88 USD.

Back to Top
ALPHA SPREAD
Follow us
Join more than 265,200+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.